| 0.3 0.025 (9.13%) | 12-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.43 | 1-year : | 0.5 |
| Resists | First : | 0.36 | Second : | 0.43 |
| Pivot price | 0.27  |
|||
| Supports | First : | 0.25 |
Second : | 0.18 |
| MAs | MA(5) : | 0.31  |
MA(20) : | 0.26 |
| MA(100) : | 0.64 |
MA(250) : | 1.27 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 60.4 |
D(3) : | 63.2 |
| RSI | RSI(14): 51 |
|||
| 52-week | High : | 3.07 | Low : | 0.15 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ UPH ] has closed below upper band by 37.2%. Bollinger Bands are 26.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.31 - 0.31 | 0.31 - 0.32 |
| Low: | 0.28 - 0.28 | 0.28 - 0.28 |
| Close: | 0.3 - 0.3 | 0.3 - 0.3 |
UpHealth, Inc. operates as a digital health services company. It provides a patient-centric digital health technologies and tech-enabled services to manage health and integrate care in the areas of integrated care management, virtual care infrastructure, and services. The company's solutions include Syntranet Core Platform, an integrated care management platform; Cloudbreak, a provider of unified telemedicine solutions and digital health tools; HelloLyf from Glocal, a platform that delivers primary care and specialty consultations; and MedQuest Pharmacy, a full-service retail and compounding licensed pharmacy that dispenses prescribed medications shipped directly to patients. UpHealth, Inc. is headquartered in Delray Beach, Florida.
Thu, 30 Nov 2023
Bankrupt health care company to have warrants delisted from NYSE - South Florida Business Journal - The Business Journals
Tue, 21 Nov 2023
UpHealth resumes trading on NYSE with focus on digital healthcare - Investing.com India
Thu, 16 Nov 2023
GTCR to Acquire Cloudbreak Health - PR Newswire
Thu, 16 Nov 2023
UpHealth Enters into Definitive Agreement for Sale of Cloudbreak Health Business to GTCR for $180 Million - GlobeNewswire
Fri, 20 Oct 2023
Thrasys, Inc., a Subsidiary of Debtor UpHealth Holdings, Inc., Files Voluntary Reorganization Under Chapter 11 of the ... - Yahoo Finance
Tue, 19 Sep 2023
UpHealth Puts Unit in Bankruptcy After Losing SPAC Fee Ruling - Bloomberg
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 18 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 47 (%) |
| Held by Institutions | 28.7 (%) |
| Shares Short | 629 (K) |
| Shares Short P.Month | 679 (K) |
| EPS | -4.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.65 |
| Profit Margin | -49.1 % |
| Operating Margin | 5 % |
| Return on Assets (ttm) | 0.3 % |
| Return on Equity (ttm) | -75.3 % |
| Qtrly Rev. Growth | -15.5 % |
| Gross Profit (p.s.) | 3.94 |
| Sales Per Share | 8.61 |
| EBITDA (p.s.) | 0.81 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -23 (M) |
| Levered Free Cash Flow | -27 (M) |
| PE Ratio | -0.07 |
| PEG Ratio | 0 |
| Price to Book value | 0.08 |
| Price to Sales | 0.03 |
| Price to Cash Flow | -0.23 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|